Respiratory Pathogen Testing

About Rhinostics

Founded in 2018 and headquartered in St. Louis, Missouri, Rhinostics is a private, commercial-stage company operating in the diagnostics sector. It has developed a proprietary platform centered on its Rhinostics Swab and automated processing workstation, which together standardize and simplify nasal sample collection and preparation for downstream molecular testing. The company targets the high-volume infectious disease testing market, including respiratory panels and hospital-acquired infection screening, by offering solutions that reduce hands-on time and potential errors. Rhinostics is positioned as a tools and consumables provider, aiming to integrate its sample collection kits into the workflows of large diagnostic laboratories and health systems.

Therapeutic Areas